NO158540C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.

Info

Publication number
NO158540C
NO158540C NO800030A NO800030A NO158540C NO 158540 C NO158540 C NO 158540C NO 800030 A NO800030 A NO 800030A NO 800030 A NO800030 A NO 800030A NO 158540 C NO158540 C NO 158540C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogy procedure
penem compounds
penem
Prior art date
Application number
NO800030A
Other languages
English (en)
Norwegian (no)
Other versions
NO158540B (no
NO800030L (no
Inventor
Stuart Walter Mccombie
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO800030L publication Critical patent/NO800030L/no
Publication of NO158540B publication Critical patent/NO158540B/no
Publication of NO158540C publication Critical patent/NO158540C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04—Preparation
    • C07D499/06—Preparation by forming the ring or condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO800030A 1979-01-10 1980-01-07 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser. NO158540C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US247179A 1979-01-10 1979-01-10
US6287579A 1979-08-01 1979-08-01
US9161079A 1979-11-05 1979-11-05

Publications (3)

Publication Number Publication Date
NO800030L NO800030L (no) 1980-07-11
NO158540B NO158540B (no) 1988-06-20
NO158540C true NO158540C (no) 1988-09-28

Family

ID=27357170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO800030A NO158540C (no) 1979-01-10 1980-01-07 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.

Country Status (39)

Country Link
EP (1) EP0013662B1 (fr)
JP (1) JPS55105686A (fr)
KR (1) KR840000606B1 (fr)
AU (1) AU539785B2 (fr)
BE (1) BE881012A (fr)
CA (1) CA1179327A (fr)
CH (1) CH651047A5 (fr)
CS (1) CS214690B2 (fr)
CY (1) CY1323A (fr)
DD (1) DD152339A5 (fr)
DE (1) DE3000343A1 (fr)
DK (1) DK6180A (fr)
ES (1) ES487488A0 (fr)
FI (1) FI800046A (fr)
FR (1) FR2446289A1 (fr)
GB (1) GB2042520B (fr)
GR (1) GR78057B (fr)
HK (1) HK12786A (fr)
HU (1) HU182661B (fr)
IE (1) IE49879B1 (fr)
IL (1) IL59081A0 (fr)
IT (1) IT1130184B (fr)
KE (1) KE3586A (fr)
LU (1) LU82066A1 (fr)
MW (1) MW180A1 (fr)
MY (2) MY8500052A (fr)
NL (1) NL8000077A (fr)
NO (1) NO158540C (fr)
NZ (1) NZ192542A (fr)
OA (1) OA06428A (fr)
PH (1) PH21780A (fr)
PL (1) PL221289A1 (fr)
PT (1) PT70666A (fr)
RO (1) RO79720A (fr)
SE (1) SE8000105L (fr)
SG (1) SG94885G (fr)
SU (1) SU1053754A3 (fr)
YU (1) YU3180A (fr)
ZA (1) ZA8086B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880793A (en) * 1978-07-24 1989-11-14 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
US5071843A (en) * 1978-07-24 1991-12-10 Merck & Co., Inc. Combination of 2-substituted carbapenems with dipeptidase inhibitors
US4397783A (en) * 1979-03-05 1983-08-09 Pfizer Inc. Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners
JPS55153789A (en) * 1979-04-11 1980-11-29 Sankyo Co Ltd Penem-3-carboxylic acid derivative and its preparation
IE49770B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3169939D1 (en) * 1980-02-28 1985-05-23 Schering Corp 2-penem compounds, pharmaceutical compositions containing them and methods for their preparation
JPS56142283A (en) * 1980-03-17 1981-11-06 Sankyo Co Ltd Penem-3-carboxylic acid derivative and its preparation
SE8101464L (sv) * 1980-03-10 1981-09-11 Sankyo Co 2-penem-3-karboxylsyraderivat, deras framstellning och anvendning
US4511512A (en) * 1980-05-01 1985-04-16 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Produktionsaktiensel skab) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
US4395418A (en) * 1980-06-06 1983-07-26 Sankyo Company Limited Penem-3-carboxylic acid derivatives
GB2083462B (en) * 1980-08-16 1984-05-02 Beecham Group Ltd 2-thiopenem derivatives
US4347183A (en) * 1981-02-02 1982-08-31 Schering Corporation Process for the synthesis of penems and carbapenems
AU8605382A (en) * 1981-07-15 1983-01-20 Sumitomo Chemical Company, Limited Penicillins and azetidinones
CA1190236A (fr) 1981-10-23 1985-07-09 Edward J.J. Grabowski Synthese d'un antibiotique
JPS595189A (ja) * 1982-07-01 1984-01-12 Sankyo Co Ltd カルバペネム−３−カルボン酸誘導体およびペネム−３−カルボン酸誘導体ならびにそれらの製法
DE3382761T2 (de) * 1982-11-29 1995-03-09 Schering Corp Verfahren zur Herstellung von Penem-Verbindungen.
US4530793A (en) * 1982-11-29 1985-07-23 Schering Corporation Processes for the production of penems
US4675317A (en) * 1983-01-25 1987-06-23 Merck & Co., Inc. 2-unsaturated alkylthio-pen-2-em-3-carboxylic acids
US4610823A (en) * 1983-01-25 1986-09-09 Merck & Co., Inc. Process for preparing substituted 2-thioxopenams and 2-substituted thiopenems
DK141784A (da) * 1983-03-14 1984-09-15 Schering Corp Penemforbindelser, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
US4504485A (en) * 1983-04-04 1985-03-12 Schering Corporation 5R,6S,8R-6-(1-Hydroxyethyl)-2-(2-carbamoyloxyethylthio)-penem-3-carboxylic acid
US4619783A (en) * 1983-06-10 1986-10-28 Pfizer Inc. Process and intermediates for the preparation of penem derivatives
US4725678A (en) * 1983-06-10 1988-02-16 Pfizer Inc. Azetidinone intermediates for the preparation of penem derivatives
US4595539A (en) * 1983-06-10 1986-06-17 Pfizer Inc. Preparation of penem derivatives and azetidinone intermediates
US4554103A (en) * 1983-07-14 1985-11-19 Schering Corporation Preparation of 4-acyloxyazetidinones from acyl nitrates and penams
EP0132101A1 (fr) * 1983-07-14 1985-01-23 Pfizer Inc. Dérivés de 2-hétérocycloalkylthiopénème
US4711886A (en) * 1984-07-02 1987-12-08 Merck & Co., Inc. β-lactam derivatives as anti-inflammatory and antidegenerative agents
US4761408A (en) * 1984-11-02 1988-08-02 Ciba-Geigy Corporation Crystalline aminomethyl compound
SG45180A1 (en) * 1987-02-17 1998-01-16 Ciba Geigy Ag A process for the manufacture of 4-acetoxy-3- hydroxy-ethyl-azetidinone
US4876365A (en) * 1988-12-05 1989-10-24 Schering Corporation Intermediate compounds for preparing penems and carbapenems
EP0937725A3 (fr) 1992-04-28 2004-12-01 Tanabe Seiyaku Co., Ltd. Méthode pour débloquer un groupe hydroxyle protégé
US5587474A (en) * 1992-06-18 1996-12-24 Tanabe Seiyaku Co., Ltd. Method for removing the protecting group for carboxyl group
GB9216102D0 (en) * 1992-07-29 1992-09-09 Smithkline Beecham Plc Pharmaceutical substances
KR100495010B1 (ko) * 2002-01-22 2005-06-13 정명구 정미기
CN115197241B (zh) * 2021-04-08 2023-11-17 四川汇宇制药股份有限公司 一种6,6-二溴青霉烷酸的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (fr) * 1977-05-09 1979-01-18
US4168314A (en) * 1977-11-17 1979-09-18 Merck & Co., Inc. 6-(1'-Hydroxyethyl)-2-aminoethylthio-pen-2-em-3-carboxylic acid
EP0003960B1 (fr) * 1978-02-02 1983-06-29 Ciba-Geigy Ag Composés thia-aza substitués en position 6, leur préparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP0013662A1 (fr) 1980-07-23
MY8600465A (en) 1986-12-31
NL8000077A (nl) 1980-07-14
PH21780A (en) 1988-02-24
CH651047A5 (de) 1985-08-30
AU5438080A (en) 1980-07-17
CA1179327A (fr) 1984-12-11
HK12786A (en) 1986-02-28
IT1130184B (it) 1986-06-11
ES8102131A1 (es) 1980-12-16
JPS55105686A (en) 1980-08-13
DE3000343A1 (de) 1980-07-31
SG94885G (en) 1986-07-25
MW180A1 (en) 1981-04-08
LU82066A1 (de) 1980-08-08
SU1053754A3 (ru) 1983-11-07
GB2042520A (en) 1980-09-24
NO158540B (no) 1988-06-20
DK6180A (da) 1980-07-11
FI800046A (fi) 1980-07-11
FR2446289A1 (fr) 1980-08-08
ES487488A0 (es) 1980-12-16
KR840000606B1 (ko) 1984-04-28
KE3586A (en) 1986-02-07
IL59081A0 (en) 1980-05-30
PL221289A1 (fr) 1980-12-01
FR2446289B1 (fr) 1983-08-19
CY1323A (en) 1986-06-27
GR78057B (fr) 1984-09-26
GB2042520B (en) 1983-01-26
CS214690B2 (en) 1982-05-28
ZA8086B (en) 1980-09-24
DD152339A5 (de) 1981-11-25
MY8500052A (en) 1985-12-31
SE8000105L (sv) 1980-07-11
PT70666A (en) 1980-02-01
BE881012A (fr) 1980-07-07
HU182661B (en) 1984-02-28
IE800034L (en) 1980-07-10
NO800030L (no) 1980-07-11
OA06428A (fr) 1981-07-31
NZ192542A (en) 1984-10-19
RO79720A (fr) 1982-08-17
YU3180A (en) 1983-10-31
IT8019049A0 (it) 1980-01-07
KR830001942A (ko) 1983-05-19
EP0013662B1 (fr) 1983-04-13
IE49879B1 (en) 1986-01-08
AU539785B2 (en) 1984-10-18

Similar Documents

Publication Publication Date Title
NO158540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.
NO149662C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive c-076-forbindelser
NO151622C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive carboxyalkyldipeptider
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO155699C (no) Fremgangsmaate ved fremstilling av hypocholesteremiske forbindelser.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO152091C (no) Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 5-substituerte 2,3-difenylthiofener
NO151702C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte acetofenoner
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO154920C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO154396C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive halovincamonderivater.
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser
NO153730C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 10-brom-e-homo-eburnan.
NO152898C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive substituerte acetofenoner.